129 related articles for article (PubMed ID: 22825892)
1. To inhale or to nebulize: treating the pulmonary vascular bed post-operatively in children with congenital heart disease.
Kenny D; Hijazi ZM
Cardiol J; 2012; 19(4):335-6. PubMed ID: 22825892
[No Abstract] [Full Text] [Related]
2. Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery.
Kirbas A; Yalcin Y; Tanrikulu N; Gürer O; Isik O
Cardiol J; 2012; 19(4):387-94. PubMed ID: 22825900
[TBL] [Abstract][Full Text] [Related]
3. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
[TBL] [Abstract][Full Text] [Related]
4. Use of inhaled iloprost in a case of pulmonary hypertension during pediatric congenital heart surgery.
Müller M; Scholz S; Kwapisz M; Akintürk H; Thul J; Hempelmann G
Anesthesiology; 2003 Sep; 99(3):743-4. PubMed ID: 12960561
[No Abstract] [Full Text] [Related]
5. Role of Vasodilator Testing in Pulmonary Hypertension.
Sharma A; Obiagwu C; Mezue K; Garg A; Mukherjee D; Haythe J; Shetty V; Einstein AJ
Prog Cardiovasc Dis; 2016; 58(4):425-33. PubMed ID: 26434988
[TBL] [Abstract][Full Text] [Related]
6. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
[TBL] [Abstract][Full Text] [Related]
8. Comparison of acute hemodynamic effects of aerosolized iloprost and inhaled nitric oxide in adult congenital heart disease with severe pulmonary arterial hypertension.
Caojin Z; Yigao H; Tao H; Wenhui H; Chunli X; Xinsheng H
Intern Med; 2012; 51(20):2857-62. PubMed ID: 23064558
[TBL] [Abstract][Full Text] [Related]
9. First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.
Sablotzki A; Czeslick E; Gruenig E; Friedrich I; Schubert S; Börgermann J; Hentschel T
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):960-2. PubMed ID: 12698166
[No Abstract] [Full Text] [Related]
10. Treatment of severe pulmonary hypertension with inhaled iloprost.
Leuchte HH; Baumgartner RA; Behr J
Ann Intern Med; 2003 Aug; 139(4):306. PubMed ID: 12965995
[No Abstract] [Full Text] [Related]
11. Is it safe to use inhaled iloprost in infants with pulmonary hypertension?
Karaagaç AT; Yildirim AI
Indian Pediatr; 2013 Nov; 50(11):1064-5. PubMed ID: 24382910
[No Abstract] [Full Text] [Related]
12. Continuous inhaled iloprost in a neonate with d-transposition of the great arteries and severe pulmonary arterial hypertension.
Dykes JC; Torres M; Alexander PJ
Cardiol Young; 2016 Mar; 26(3):571-3. PubMed ID: 26220108
[TBL] [Abstract][Full Text] [Related]
13. Iloprost for children with pulmonary hypertension after surgery to correct congenital heart disease.
Xu Z; Zhu L; Liu X; Gong X; Gattrell W; Liu J
Pediatr Pulmonol; 2015 Jun; 50(6):588-95. PubMed ID: 24610631
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
[TBL] [Abstract][Full Text] [Related]
15. Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease.
Gorenflo M; Gu H; Xu Z
Cardiology; 2010; 116(1):10-7. PubMed ID: 20424447
[TBL] [Abstract][Full Text] [Related]
16. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
17. The effect of intravenous iloprost on pulmonary artery hypertension after paediatric congenital heart surgery.
Onan IS; Ozturk E; Yildiz O; Altin HF; Odemis E; Erek E
Interact Cardiovasc Thorac Surg; 2016 Feb; 22(2):194-9. PubMed ID: 26604214
[TBL] [Abstract][Full Text] [Related]
18. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
[No Abstract] [Full Text] [Related]
19. Combined approach in ventricular septal defect and adult pulmonary hypertension.
Cingoz F; Tavlasoglu M; Sahin MA; Kurkluoglu M
Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):596-8. PubMed ID: 24570564
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
Hoeper MM; Olschewski H; Ghofrani HA; Wilkens H; Winkler J; Borst MM; Niedermeyer J; Fabel H; Seeger W
J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
